Engaging People with Diabetes in the post-Summit world

The Lancet, 2008

Diabetes Research and Clinical Practice, 2013

Remarkable progress in scientific and medical understanding has been made over the last century, leading to the development and uptake of numerous effective diabetes therapies. However, significant gaps remain between knowledge reached through research and day-to-day clinical practice to support the lasting health-protective behavioural changes people need to make in order to protect themselves from diabetes and its complications. BRIDGES, an International Diabetes Federation (IDF) programme supported by an educational grant from Lilly Diabetes, was created to identify real-world solutions, and thus achieve improved outcomes, for people with diabetes. BRIDGES provides financial support to projects testing novel hypotheses to this end -interventions trying to close the care gap by translating theories that have been tried and tested in controlled conditions into the practical know-how people require to be able to prevent type 2 diabetes and its complications. Efforts like this are needed to help halt the progression of the worldwide diabetes epidemic.

Expert Review of Cardiovascular Therapy, 2010

Revista de la Facultad de Medicina Humana, 2019

La carga mundial de diabetes, una de las principales causas de muerte, morbilidad y gastos en atención médica, ahora representa una de las mayores amenazas para la salud y el desarrollo mundiales. Los principales determinantes biológicos y de comportamiento de la diabetes son las dietas de azúcares y grasas procesadas, los bajos niveles de actividad física, el sobrepeso y la obesidad (Birn, Pillay, y Holtz, 2017). Como una de las cuatro principales enfermedades no transmisibles (ENT), Diabetes Mellitus (DM) ha atraído una gran atención por parte de las autoridades sanitarias mundiales. De hecho, la Organización Mundial de la Salud ha desarrollado una estrategia para abordar las crecientes tasas de DM, incluida la prevención, la gestión, el acceso a medicamentos esenciales y la vigilancia. Un enfoque integral que integre la política de atención médica, la promoción de la salud y la educación para la salud es necesario para la prevención y posterior tratamiento de la diabetes en todo el mundo.

Handbook of Global Health

Diabetes mellitus is a chronic noncommunicable disease contributing to a major share of premature morbidity and mortality in age 30-70. Globally, the estimated number of people living with diabetes has risen from 108 million in 1980 to 476 million in 2017 with the prevalence of diabetes among adults over 18 years of age rising from 4.7% in 1980 to 8.5% in 2014. Worldwide, 1.4 million deaths and 2.5% of total deaths are attributed to diabetes in 2017. The rapid rise in the prevalence of diabetes in low-and middle-income countries suggests the changing course of the diabetes epidemiology that it is a more widespread problem across the rich and poor nations as well as among the rich and poor of the nations. Among WHO regions, the Eastern Mediterranean, part of Asia, and Africa have higher prevalence of diabetes as compared to other countries, while Southeast Asia and Western Pacific regions have the largest numbers of people with diabetes. Contributed by the complex interaction between genetic, behavioral, and environmental factors, globally, the prevalence of diabetes accentuates at the age of 45-49 with one in ten older adults diagnosed with diabetes with the peak prevalence rate of 24% in the oldest old age of 85-89. As a hormonal and metabolic chronic condition, diabetes is a main driver of several other comorbid health outcomes such as cardiovascular diseases, mental health disorders, kidney diseases, eye-related disorders, neuropathy, rheumatoid arthritis, bone-related diseases, etc. The global burden of diabetes not only poses serious challenges to public health but tend to have an overwhelming effect on the global development through substantial social and economic loss. Therefore, preventing and controlling diabetes with multisectoral efforts and effective interventions are very important. Early screening and adequate awareness and health-care intervention are essential to reduce the global burden of diabetes.

Pediatric Diabetes, 2009

Diabetes Management, 2012

Diabetes Care, 2015

Lancet, 2006

Health Affairs, 2012

Continued increases in the prevalence of and disproportionate health spending associated with type 2 diabetes argue for policies focused on preventing that condition and treating it appropriately, even as we strive to improve coordination of care for coexisting chronic diseases. This article argues that four policy paradigm shifts will be necessary to achieve that specific emphasis on type 2 diabetes: conceptually integrating primary and secondary prevention along a clinical continuum; recognizing the central importance of early detection of prediabetes and undiagnosed diabetes in implementing cost-effective prevention and control; integrating community and clinical expertise, and resources, within organized and affordable service delivery systems; and sharing and adopting evidence-based policies at the global level.